92 related articles for article (PubMed ID: 3823114)
1. [Radioimmunoassay of the progestagen dienogest using various methods of sample preparation of plasma].
Hieu DK; Reddersen G; Wehrberger K; Hobe G
Pharmazie; 1986 Oct; 41(10):711-4. PubMed ID: 3823114
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunologic determination of the progestagen dienogest in plasma and saliva].
Hobe G; Klinger G; Reddersen G; Erdmann A; Klinger G
Pharmazie; 1986 Nov; 41(11):772-4. PubMed ID: 3484359
[TBL] [Abstract][Full Text] [Related]
3. Studies on the biotransformation of the progestagen dienogest in the rabbit.
Hobe G; Schön R; Wehrberger K; Schade W; Ritter P; Hillesheim HG
Exp Clin Endocrinol; 1989 Sep; 94(1-2):203-10. PubMed ID: 2599019
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
Hillesheim HG; Ritter P; Valentin U; Hobe G
Exp Clin Endocrinol; 1989 Sep; 94(1-2):194-202. PubMed ID: 2599018
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a high throughput direct radioimmunoassay for the quantitative determination of serum and plasma melatonin (N-acetyl-5-methoxytryptamine) in mice.
Welp A; Manz B; Peschke E
J Immunol Methods; 2010 Jun; 358(1-2):1-8. PubMed ID: 20363223
[TBL] [Abstract][Full Text] [Related]
6. Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat and Valette.
Klinger G; Piater T; Jäger R; Küntzel B; Schön R; Hobe G
Pharmazie; 2001 Apr; 56(4):325-8. PubMed ID: 11338674
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of endometriosis with dienogest].
Köhler G; Göretzlehner G; Amon I
Zentralbl Gynakol; 1987; 109(12):795-801. PubMed ID: 3630463
[TBL] [Abstract][Full Text] [Related]
8. [Bovine serum albumin conjugates of the new progestagen dienogest, synthesis and immunogenic properties].
Hobe G; Do Khac Hieu ; Reddersen G; Wesemann R; Hübner M; Menzenbach B; Wagner H; Römer J; Frankenberg G; Schubert K
Pharmazie; 1986 Sep; 41(9):627-30. PubMed ID: 3797451
[TBL] [Abstract][Full Text] [Related]
9. [The endocrinologic profile of metabolites of the progestin dienogest].
Oettel M; Kaufmann G; Kurischko A
Pharmazie; 1993 Jul; 48(7):541-5. PubMed ID: 8415850
[TBL] [Abstract][Full Text] [Related]
10. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
[TBL] [Abstract][Full Text] [Related]
11. Direct radioimmunoassay of progesterone in bovine plasma using danazol (17-alpha-2,4-pregnadien-20-yno(2,3-d)isoxazol-17-ol) as a displacing agent.
Carrière PD; Lee B
Can J Vet Res; 1994 Jul; 58(3):230-3. PubMed ID: 7954127
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of parameters of liver metabolism in intermediate-term use of the gestagen dienogest in the treatment of endometriosis].
Köhler G; Lembke S; Brachmann K; Foth D; Happke S
Zentralbl Gynakol; 1989; 111(12):807-10. PubMed ID: 2763750
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin determination by radioimmunoassay. III. Improvement to subpicogram sensitivity and application to blood levels in cyclic cattle.
Schams D
Acta Endocrinol (Copenh); 1983 Jun; 103(2):180-3. PubMed ID: 6683055
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bioanalytical determinations of Iloprost, a chemically stable PGI2 mimetic, by conventional radioimmunoassay (RIA) and scintillation proximity assay (SPA).
Hildebrand M; Louton T; Schütt A
Eicosanoids; 1992; 5(1):5-8. PubMed ID: 1384587
[TBL] [Abstract][Full Text] [Related]
15. Development, validation and practical use of a sensitive and specific radioimmunoassay for the determination of iloprost.
Hildebrand M; Nieuweboer B; Biere H; Klar U; Seemann G; Krause W; Jakobs U
Eicosanoids; 1990; 3(3):165-9. PubMed ID: 1700724
[TBL] [Abstract][Full Text] [Related]
16. [The development of a new highly potent progestagen, STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-13 beta-methylgona-4,9-dien-3-one) (proceedings)].
Ponsold K
Pharmazie; 1979; 34(5-6):312-4. PubMed ID: 515134
[No Abstract] [Full Text] [Related]
17. Studies on biotransformation of STS 557.
Schubert K; Hobe G; Kaufmann G; Schumann G; Wehrberger K; Hörhold C
Exp Clin Endocrinol; 1983 Feb; 81(2):168-74. PubMed ID: 6682794
[TBL] [Abstract][Full Text] [Related]
18. A monolithic-phase based on-line extraction approach for determination of pharmaceutical components in human plasma by HPLC-MS/MS and a comparison with liquid-liquid extraction.
Naxing Xu R; Fan L; Kim GE; El-Shourbagy TA
J Pharm Biomed Anal; 2006 Feb; 40(3):728-36. PubMed ID: 16289933
[TBL] [Abstract][Full Text] [Related]
19. SPE/RIA vs LC/MS for measurement of low levels of budesonide in plasma.
Dimova H; Wang Y; Pommery S; Moellmann H; Hochhaus G
Biomed Chromatogr; 2003 Jan; 17(1):14-20. PubMed ID: 12583000
[TBL] [Abstract][Full Text] [Related]
20. 19-nortestosterone detection in canine plasma after intramuscular administration of 19-nortestosterone phenylpropionate.
Macdougall DF; Jondorf WR
Res Vet Sci; 1989 Nov; 47(3):399-401. PubMed ID: 2595098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
